Clinical Trial Update: Low-Dose Enoxaparin in Psoriasis [NA]

View source ↗

Summary

A clinical trial is evaluating low-dose enoxaparin for psoriasis. The study is currently not yet recruiting, with Zagazig University listed as the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Zagazig University | Conditions: Psoriasis | NA | Status: NOT_YET_RECRUITING